Nottingham

 One of the main foci of our research is to explore new avenues in MS treatment and toOne of the main foci of our research is to explore new avenues in MS treatment and togain a greater understanding of how best to use our current disease modifyingtherapies (DMTs). There are 9 approved DMTs in the UK and more are becomingavailable every year. All of them aid in decreasing inflammation and it is thought theymight even protect neurons. All DMTs work with the overall aim to improve the clinicaloutcome of people with MS.DMTs have been found to decrease the number and severity of relapse, slow thedevelopment and progression of brain and spinal cord lesions, and reducedisabilities. However, there is currently little to no evidence on which type of DMT isbest, for which patients, and when would be the most beneficial time to use them toget the best results.Stronger treatments are usually associated with riskier side effects. Therefore, thequestion is, can we find the right balance of effectiveness and side effects? Our aim,working with many other MS research teams across the world, is to provide thisevidence in order to find the best treatment for each patient.

Read More